Cardiovascular, Mortality, and Kidney Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes: a Systematic Review and Meta-Analysis of Randomised Trials
What happens during a telehealth GLP-1 consultation
Over the previous 12 months, the patient had lost 25 pounds on gradually increasing doses of the phentermine/topiramate combination medication, with very slow weight loss and with an absence of weight loss in the preceding 3 months
From randomization to week 104, weight regain was +7.6 kg in placebo, +8.7 kg in liraglutide, +5.4 kg in exercise, and only +3.5 kg in the combination arm [15]
For patients managing anxiety alongside weight loss goals, the article on Ozempic and anxiety covers the neurological side effects worth monitoring
PMID: 41506148